A detailed history of Vanguard Group Inc transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 655,947 shares of PRPH stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
655,947
Previous 618,763 6.01%
Holding current value
$1.49 Million
Previous $4 Million 31.53%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.18 - $7.35 $155,429 - $273,302
37,184 Added 6.01%
655,947 $2.74 Million
Q1 2024

May 10, 2024

BUY
$4.47 - $6.47 $42,089 - $60,921
9,416 Added 1.55%
618,763 $4 Million
Q4 2023

Feb 14, 2024

BUY
$4.35 - $5.1 $32,655 - $38,285
7,507 Added 1.25%
609,347 $2.75 Million
Q2 2023

Aug 14, 2023

SELL
$7.15 - $9.78 $105,934 - $144,900
-14,816 Reduced 2.4%
601,840 $4.37 Million
Q1 2023

May 15, 2023

BUY
$6.62 - $9.57 $187,259 - $270,706
28,287 Added 4.81%
616,656 $4.7 Million
Q4 2022

Feb 10, 2023

BUY
$8.78 - $12.47 $54,084 - $76,815
6,160 Added 1.06%
588,369 $5.67 Million
Q3 2022

Nov 14, 2022

SELL
$8.96 - $14.7 $161,280 - $264,600
-18,000 Reduced 3.0%
582,209 $6.57 Million
Q2 2022

Aug 12, 2022

BUY
$6.52 - $13.24 $571,152 - $1.16 Million
87,600 Added 17.09%
600,209 $7.61 Million
Q1 2022

May 13, 2022

BUY
$6.2 - $7.87 $90,960 - $115,460
14,671 Added 2.95%
512,609 $3.59 Million
Q4 2021

Feb 14, 2022

BUY
$5.13 - $7.89 $156,957 - $241,402
30,596 Added 6.55%
497,938 $3.57 Million
Q3 2021

Nov 12, 2021

BUY
$4.89 - $7.82 $4,909 - $7,851
1,004 Added 0.22%
467,342 $2.43 Million
Q2 2021

Aug 13, 2021

BUY
$4.61 - $6.83 $2.15 Million - $3.19 Million
466,338 New
466,338 $2.89 Million

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $36.4M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.